Back to Trades
Fitzgerald Meghan
DirectorCIK 0001349297
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 2
- Active
- 2025–2026
Fitzgerald Meghan, Director, has filed 9 SEC reports (2025–2026), spread across 2 companies, totaling $6.1M in disclosed volume. Weighing $0 bought versus $3.3M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Sep 18 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Director | Grant | $416.7K |
| Sep 17 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Director | Sell | $203.2K |
| Sep 14 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Director | Tax withheld | $71.4K |
| Sep 10 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Insider | Sell | $798.0K |
| Jul 2 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Director | Sell | $349.0K |
| May 28 | THC TENET HEALTHCARE CORP | Fitzgerald Meghan | Insider | Award | $0 |
| May 26 | THC TENET HEALTHCARE CORP | Fitzgerald Meghan | Insider | Exercise | $85.7K |
| Mar 30 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Insider | Sell | $1.9M |
| Sep 12 | ROIV Roivant Sciences Ltd. | Fitzgerald Meghan | Insider | Grant | $477.3K |
9 filings